UnitedHealth: Why It's Still Not Too Late To Buy The Turnaround

JR ResearchInvesting Group LeaderFollow5ShareSavePlay(9min)Comment(1)SummaryUnitedHealth Group remains a battleground stock between the bulls and bears. 2026 is positioned as a reset year amid ongoing regulatory and margin pressures.UNH's dominant Medicare Advantage position and integrated value-based care model provide margin improvement levers, despite below-trend EPS growth projections through 2027.Valuation already reflects significant pessimism, with UNH trading at a forward P/E that's 18% below its 10-year average, signaling risks are largely priced in.I maintain a Buy rating, expecting constructive consolidation and upside toward an interim $370 price target as earnings clarity emerges through 2026.Looking for a helping hand in the market? Members of Ultimate Growth Investing get exclusive ideas and guidance to navigate any climate. Learn More » jetcityimage/iStock Editorial via Getty Images UnitedHealth: 2026 Should Be the Reset Year Is the worst really over for investors of UnitedHealth Group Incorporated (UNH)? At this point, UNH has become a true battleground stock in the healthcare sector. TheThis article was written byJR Research47.37K FollowersFollowJR Research is an opportunistic investor. I was recognized by TipRanks as a Top Analyst, and also by Seeking Alpha as a "Top Analyst To Follow" for Technology, Software, and Internet, as well as for Growth and GARP. I identify attractive risk/reward opportunities supported by robust price action to potentially generate alpha well above the S&P 500. My picks have consistently demonstrated market outperformance over time. My approach combines timely and sharp price action analysis with fundamentals as my foundation. I also tend to avoid overhyped and overvalued stocks while capitalizing on battered stocks with significant upside recovery possibilities. I run the investing group Ultimate Growth Investing which specializes in identifying high-potential opportunities across various sectors. My main ideas revolve around stocks with strong growth potential, and also well-beaten contrarian plays. I designed the group for investors seeking to capitalize on growth stocks with solid fundamentals, robust buying momentum, and appealing turnaround plays to generate alpha consistently. Learn moreAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.